Stocks WAT Financial statements
Financial statementsWATERS CORP /DE/ financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data WATERS CORP /DE/ files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,167 | 2,309 | 2,420 | 2,407 | 2,365 | 2,786 | 2,972 | 2,956 | 2,958 | 3,165 |
| Cost of revenue | 891 | 947 | 993 | 1,011 | 1,007 | 1,157 | 1,248 | 1,195 | 1,200 | 1,289 |
| Gross profit | 1,276 | 1,362 | 1,427 | 1,396 | 1,359 | 1,629 | 1,724 | 1,761 | 1,758 | 1,876 |
| Research and development | 125 | 133 | 143 | 143 | 141 | 168 | 176 | 175 | 183 | 196 |
| Selling, general and administrative | 512 | 544 | 537 | 535 | 554 | 627 | 658 | 736 | 690 | 830 |
| Operating income | 625 | 662 | 740 | 708 | 645 | 822 | 873 | 818 | 826 | 803 |
| Interest expense | 44.9 | 56.8 | 48.6 | 48.7 | 49.1 | 44.9 | 48.8 | 98.9 | 89.7 | 69.5 |
| Interest income | 20.7 | 36.1 | 38.8 | 22.1 | 16.3 | 12.2 | 11 | 16.6 | 17.4 | 18.8 |
| Other non-operating income | -0.7 | -0.34 | -47.8 | -3.59 | -1.78 | 17.2 | 2.23 | 0.81 | 0.78 | 3.06 |
| Pre-tax income | 600 | 641 | 682 | 678 | 611 | 806 | 838 | 736 | 755 | 755 |
| Income tax | 78.6 | 621 | 88.4 | 86 | 89.3 | 113 | 130 | 94 | 117 | 112 |
| Net income | 522 | 20.3 | 594 | 592 | 522 | 693 | 708 | 642 | 638 | 643 |
| EBITDA | 677 | 724 | 798 | 762 | 714 | 893 | 945 | 902 | 913 | 891 |
| EPS, basic | 6.46 | 0.25 | 7.71 | 8.76 | 8.40 | 11.25 | 11.80 | 10.87 | 10.75 | 10.80 |
| EPS, diluted | 6.41 | 0.25 | 7.65 | 8.69 | 8.36 | 11.17 | 11.73 | 10.84 | 10.71 | 10.76 |
| Shares, basic (weighted) | 80.8 | 79.8 | 77 | 67.6 | 62.1 | 61.6 | 60 | 59.1 | 59.3 | 59.5 |
| Shares, diluted (weighted) | 81.4 | 80.6 | 77.6 | 68.2 | 62.4 | 62 | 60.3 | 59.3 | 59.6 | 59.7 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 506 | 642 | 796 | 336 | 437 | 501 | 481 | 395 | 325 | 588 |
| Short-term investments | 2,307 | 2,751 | 939 | 1.43 | 6.45 | 68.1 | 0.86 | 0.9 | 0.93 | |
| Receivables | 489 | 534 | 568 | 588 | 573 | 613 | 723 | 702 | 733 | 829 |
| Inventory | 263 | 270 | 292 | 321 | 304 | 356 | 456 | 516 | 477 | 572 |
| Other current assets | 70.4 | 72.3 | 68.1 | 67.1 | 80.3 | 90.9 | 104 | 138 | 133 | 159 |
| Total current assets | 3,635 | 4,270 | 2,663 | 1,312 | 1,401 | 1,629 | 1,764 | 1,753 | 1,669 | 2,148 |
| Property, plant and equipment | 337 | 349 | 343 | 417 | 494 | 548 | 582 | 639 | 651 | 642 |
| Lease right-of-use assets | 93.4 | 93.3 | 84.7 | 86.5 | 84.6 | 74.2 | 81 | |||
| Goodwill | 352 | 360 | 356 | 356 | 444 | 438 | 430 | 1,305 | 1,296 | 1,340 |
| Intangible assets | 207 | 228 | 247 | 240 | 259 | 242 | 227 | 629 | 568 | 558 |
| Long-term investments | 0 | 7 | ||||||||
| Other non-current assets | 130 | 117 | 119 | 138 | 149 | 153 | 191 | 216 | 296 | 308 |
| Total assets | 4,662 | 5,324 | 3,727 | 2,557 | 2,840 | 3,095 | 3,281 | 4,627 | 4,554 | 5,077 |
| Accounts payable | 67.7 | 64.5 | 68.2 | 49 | 72.2 | 96.8 | 93.3 | 84.7 | 99.9 | 104 |
| Accrued liabilities | 57.5 | 69 | 23 | 43.5 | 72.2 | 101 | 103 | 69.4 | 94 | 100 |
| Short-term debt | 125 | 100 | 0.18 | 100 | 150 | 0 | ||||
| Total current liabilities | 520 | 606 | 449 | 591 | 805 | 681 | 786 | 790 | 790 | 1,239 |
| Long-term debt | 1,702 | 1,898 | 1,148 | 1,581 | 1,207 | 1,514 | 1,525 | 2,306 | 1,626 | 947 |
| Lease liabilities | 66.9 | 68.2 | 59.6 | 62.1 | 58.9 | 50.3 | 53 | |||
| Other non-current liabilities | 54.8 | 62.6 | 76.3 | 80.6 | 98 | 89.8 | 118 | 138 | 184 | 161 |
| Total liabilities | 2,360 | 3,091 | 2,160 | 2,773 | 2,608 | 2,727 | 2,777 | 3,477 | 2,725 | 2,515 |
| Total debt | 1,830 | 1,898 | 1,148 | 1,685 | 1,360 | 1,520 | 1,580 | 2,360 | 1,630 | 1,410 |
| Paid-in capital | 1,607 | 1,745 | 1,835 | 1,927 | 2,029 | 2,115 | 2,200 | 2,266 | 2,341 | 2,416 |
| Retained earnings | 5,385 | 5,405 | 5,995 | 6,587 | 7,108 | 7,801 | 8,509 | 9,151 | 9,789 | 10,431 |
| Treasury stock | -4,476 | -4,808 | -6,146 | -8,613 | -8,789 | -9,438 | -10,064 | -10,134 | -10,148 | -10,162 |
| Other comprehensive income | -216 | -110 | -118 | -119 | -118 | -112 | -142 | -134 | -155 | -125 |
| Shareholders' equity | 2,302 | 2,234 | 1,567 | -216 | 232 | 368 | 504 | 1,150 | 1,829 | 2,562 |
| Total equity | 2,302 | 2,234 | 1,567 | -216 | 232 | 368 | 504 | 1,150 | 1,829 | 2,562 |
| Total liabilities and equity | 4,662 | 5,324 | 3,727 | 2,557 | 2,840 | 3,095 | 3,281 | 4,627 | 4,554 | 5,077 |
| Shares outstanding | 80 | 79.3 | 73.1 | 62.6 | 62.3 | 60.7 | 59.1 | 0.06 | 59.4 | 59.5 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 522 | 20.3 | 594 | 592 | 522 | 693 | 708 | 642 | 638 | 643 |
| Depreciation and amortization | 51.7 | 61.5 | 58 | 53.8 | 68.7 | 71.6 | 72 | 84.6 | 87 | 88.1 |
| Stock-based compensation | 41 | 39.4 | 37.5 | 38.6 | 36.9 | 29.9 | 42.6 | 36.9 | 44.7 | 54.1 |
| Deferred income tax | 1.2 | 45.5 | 2.41 | 9.62 | -2.69 | 16.6 | -32 | -1.2 | -0.88 | -14.7 |
| Change in receivables | -31.7 | -24 | -47.9 | -22.2 | 37.5 | -62.4 | -138 | 49.2 | -66.2 | -55.5 |
| Change in inventory | -20.1 | 0.73 | -25.4 | -31.9 | 18.9 | -67.3 | -102 | -45.4 | 20.9 | -65.9 |
| Change in payables | 6.84 | 3.18 | -81.7 | 9.78 | 141 | 46.1 | 61 | -79.5 | 61.6 | -89 |
| Cash from operations | 643 | 698 | 604 | 643 | 791 | 747 | 612 | 603 | 762 | 653 |
| Capital expenditures | -161 | -142 | -113 | |||||||
| Acquisitions | -5.61 | -31.5 | 0 | -80.5 | 0 | 0 | -1,282 | 0 | -35.1 | |
| Purchases of investments | -2,396 | -2,960 | -1,006 | -37 | -25.9 | -280 | -11.4 | -1.79 | -3.73 | 0 |
| Sales and maturities of investments | 2,005 | 2,522 | 2,825 | 978 | 20.9 | 218 | 78 | 1.77 | 4.61 | 0 |
| Cash from investing | -488 | -536 | 1,683 | 769 | -264 | -232 | -108 | -1,442 | -143 | -152 |
| Debt issued | 485 | 1,480 | 0.27 | 926 | 315 | 510 | 205 | 1,450 | 170 | 70 |
| Debt repaid | -325 | -1,310 | -850 | -390 | -640 | -350 | -145 | -670 | -900 | -290 |
| Stock issued | 56 | 91 | 45 | 46 | 59 | 46 | 32 | 18 | 21 | 10 |
| Share buybacks | -326 | -333 | -1,315 | -2,469 | -196 | -649 | -626 | -70.3 | -13.5 | -14.7 |
| Cash from financing | -116 | -63.9 | -2,120 | -1,873 | -441 | -438 | -510 | 755 | -697 | -237 |
| Exchange rate effect | -21.3 | 38.7 | -14.3 | 0.22 | 15.1 | -12.8 | -14.8 | -0.95 | 7.92 | -0.62 |
| Net change in cash | 18 | 137 | 154 | -461 | 101 | 64.5 | -20.7 | -85.5 | -69.7 | 262 |
| Free cash flow | 442 | 620 | 540 | |||||||
| Interest paid | 43.6 | 56.5 | 50.8 | 42.8 | 52.1 | 42.4 | 48.1 | 94.1 | 92.1 | 44.6 |
| Income taxes paid | 50 | 70.6 | 159 | 88 | 97.6 | 154 | 160 | 243 | 183 | 244 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | 7.1% | Operating income / revenue. |
| Pre-tax margin | 4.4% | Pre-tax income / revenue. |
| Net margin | 3.6% | Net income / revenue. |
| Effective tax rate | 19.1% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 1.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 0.7% | Net income / average total assets. |
| Return on invested capital (ROIC) | 1.4% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 6.9% | Research and development expense / revenue. |
| SG&A / revenue | 26.8% | Selling, general and administrative expense / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 7.0% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 2.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 6.0% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | 6.7% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 2.9% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 6.7% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -2.9% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -2.8% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income CAGR, 5y | 4.5% | Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -2.5% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -2.0% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 4.5% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 0.8% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -3.2% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income CAGR, 5y | 4.3% | Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EPS growth, 1y | 0.5% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | -2.8% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS CAGR, 5y | 5.2% | Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -14.4% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 2.2% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -3.8% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -12.9% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Book value growth, 1y | 40.1% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 71.9% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 61.6% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 11.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 15.7% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 12.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -0.3% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | -0.9% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.86x | Current assets / current liabilities. |
| Quick ratio | 1.05x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.22x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.33x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 20.5% | Total debt / total assets. |
| Liabilities / assets | 38.6% | Total liabilities / total assets. |
| Net debt | $4.55B | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Interest coverage | 2.21x | Operating income / interest expense. |
| Working capital | $2.07B | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 72.5% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$2.75B | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.19x | Revenue / average total assets. |
| Fixed asset turnover | 3.12x | Revenue / average property, plant and equipment. |
| Receivables turnover | 2.34x | Revenue / average receivables. |
| Days sales outstanding | 156 days | 365 x average receivables / revenue. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $4.01 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $0.05 | Revenue / diluted weighted shares. |
| Book value per share | $154.70 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$27.97 | Tangible book value / shares outstanding. |
| Cash per share | $5.49 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $42.59B | Share price x shares outstanding. |
| Enterprise value | $47.14B | Market cap + total debt - cash - short-term investments. |
| P/E | 256x | Market cap / net income. Only when net income is positive. |
| P/S | 9.17x | Market cap / revenue. |
| P/B | 2.80x | Market cap / shareholders' equity. Only when equity is positive. |
| EV/Sales | 10.2x | Enterprise value / revenue. |
| EV/EBIT | 143x | Enterprise value / operating income, when both are positive. |
| Earnings yield | 0.4% | Net income / market cap (the inverse of P/E). |
What was WATERS CORP /DE/'s revenue in fiscal 2025?
WATERS CORP /DE/ reported revenue of $3.17B for fiscal 2025, 7% higher than the year before.
Was WATERS CORP /DE/ profitable in fiscal 2025?
Yes. Net income was $642.6M, a net margin of 20.3%.
How much free cash flow did WATERS CORP /DE/ generate in fiscal 2025?
Cash from operations of $652.6M minus capital expenditures of $112.7M left free cash flow of $539.8M.